There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...
The closest thing we have to an HIV vaccine has hit the market – but less than a tenth of the doses needed to change the ...
Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "The progress that science has made against HIV/AIDS is ...
Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: HIV is neither the cause nor the sole cause of AIDS. This nonsense has been ...
Why is HIV still incurable? Understand the virus's characteristics, early symptoms, and how ART drugs control it.
Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...
Kegoratile Aphane did not flinch when the needle pierced the skin of her right buttock, injecting a yellow-colored drug ...
A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or infections the body might otherwise fight off — sent loved ones into the streets ...
A new study led by researchers at Emory University's Rollins School of Public Health, published Monday by JAMA Network Open, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results